These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7634402)
1. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Egner PA; Gange SJ; Dolan PM; Groopman JD; Muñoz A; Kensler TW Carcinogenesis; 1995 Aug; 16(8):1769-73. PubMed ID: 7634402 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273 [TBL] [Abstract][Full Text] [Related]
4. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553 [TBL] [Abstract][Full Text] [Related]
5. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. Groopman JD; DeMatos P; Egner PA; Love-Hunt A; Kensler TW Carcinogenesis; 1992 Jan; 13(1):101-6. PubMed ID: 1733561 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz. Scholl P; Musser SM; Kensler TW; Groopman JD Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461 [TBL] [Abstract][Full Text] [Related]
7. Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis). Li Y; Su J; Qin L; Egner PA; Wang J; Groopman JD; Kensler TW; Roebuck BD Cancer Lett; 2000 Jun; 154(1):79-83. PubMed ID: 10799742 [TBL] [Abstract][Full Text] [Related]
8. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587 [TBL] [Abstract][Full Text] [Related]
9. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242 [TBL] [Abstract][Full Text] [Related]
10. Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat. Liu YL; Roebuck BD; Yager JD; Groopman JD; Kensler TW Toxicol Appl Pharmacol; 1988 May; 93(3):442-51. PubMed ID: 3130679 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Maxuitenko YY; MacMillan DL; Kensler TW; Roebuck BD Carcinogenesis; 1993 Nov; 14(11):2423-5. PubMed ID: 8242875 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217 [TBL] [Abstract][Full Text] [Related]
14. Chemoprevention by inducers of carcinogen detoxication enzymes. Kensler TW Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588 [TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats. Walton M; Egner P; Scholl PF; Walker J; Kensler TW; Groopman JD Chem Res Toxicol; 2001 Jul; 14(7):919-26. PubMed ID: 11453740 [TBL] [Abstract][Full Text] [Related]
16. Effects of dietary oltipraz and ethoxyquin on aflatoxin B1 biotransformation in non-human primates. Bammler TK; Slone DH; Eaton DL Toxicol Sci; 2000 Mar; 54(1):30-41. PubMed ID: 10746929 [TBL] [Abstract][Full Text] [Related]
19. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Kensler TW; Egner PA; Trush MA; Bueding E; Groopman JD Carcinogenesis; 1985 May; 6(5):759-63. PubMed ID: 3924431 [TBL] [Abstract][Full Text] [Related]
20. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Kensler TW; Curphey TJ; Maxiutenko Y; Roebuck BD Drug Metabol Drug Interact; 2000; 17(1-4):3-22. PubMed ID: 11201301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]